1. Enter Merck
It’s kind of perfect. Johnson & Johnson’s very helpful one-shot vaccine is approved. But J&J is behind on production. So the Biden administration brokered an arranged marriage in which Big Pharma rival Merck will take on a portion of the J&J shot manufacturing.
The administration has also been pushing J&J in other ways:
The company and its c…
Join Bulwark+ to unlock the rest
Become a paying member of The Bulwark to get access to this post and other subscriber-only content. A subscription gets you:
- Unlimited access to articles and newsletters including The Triad by JVL and Receipts by Catherine Rampell.
- Ad-free editions of our shows (with transcripts) and member-only shows like The Secret Podcast.
- Plus community chats and commenting features. Your support helps keep our work sustainable and available to those who cannot afford a membership. Cancel anytime.